Vertex Ventures

Vertex Ventures is a global venture capital firm specializing in early-stage investments. With offices across the U.S., China, Israel, India, and Southeast Asia, they focus on enterprise and infrastructure companies, supporting innovative entrepreneurs with operational expertise and access to capital.

Jeff Chang

Managing Director

Kee Lock Chua

Managing Partner

Lori Hu

Managing Director

Yanai Oron

General Partner

Domenic Perri

Operating Partner

In Sik Rhee

General Partner

Insik Rhee

General Partner

Chase Roberts

Principal

Gideon Shichman

General Partner

Sin Hui Tham

Managing Director, Fund Operations

Hanming Wang

Senior Associate

Zhijin Xia

Partner

Past deals in Intellectual Property

Vectara

Seed Round in 2023
Vectara offers a generative AI platform for embedding AI features into applications. Its serverless Retrieval Augmented Generation API enables businesses to integrate conversational AI and question-answering securely, with minimal hallucination, explainable results, and real-time updatability.

Vectara

Seed Round in 2022
Vectara offers a generative AI platform for embedding AI features into applications. Its serverless Retrieval Augmented Generation API enables businesses to integrate conversational AI and question-answering securely, with minimal hallucination, explainable results, and real-time updatability.

PatSnap

Series E in 2021
Founded in 2007, PatSnap is a global leader in innovation intelligence. Its AI-powered platform provides patent, market, and technology insights to over 10,000 customers across 50 countries, supporting them from ideation to commercialization.

Chipscreen

Venture Round in 2015
Chipscreen is an integrated biotech company based in Shenzhen, specializing in the discovery and development of novel small molecule pharmaceuticals. Established in 2001 as a Sino-foreign joint venture by a group of esteemed Chinese returnees with significant academic and industrial expertise, the company employs a proprietary chemical genomics-based discovery platform to create a diverse portfolio of clinical and preclinical stage programs across various therapeutic areas. Chipscreen emphasizes a science-driven approach to drug discovery, supported by strong capabilities in pipeline development, intellectual property management, and regulatory compliance. The company’s strategy involves generating differentiated drug candidates, which may be developed independently or in collaboration with partners throughout the research, preclinical, and clinical stages.

PatSnap

Series A in 2014
Founded in 2007, PatSnap is a global leader in innovation intelligence. Its AI-powered platform provides patent, market, and technology insights to over 10,000 customers across 50 countries, supporting them from ideation to commercialization.

Sidense

Series C in 2013
Sidense is a leading developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in patented one-time programmable OTP memory and logic NVM solutions that are designed for code storage and processor configuration. Sidense's technology enables semiconductor and systems companies to integrate IP cores into their system-on-chip (SOC) designs, helping to differentiate products with a lower footprint.

Sidense

Series C in 2011
Sidense is a leading developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in patented one-time programmable OTP memory and logic NVM solutions that are designed for code storage and processor configuration. Sidense's technology enables semiconductor and systems companies to integrate IP cores into their system-on-chip (SOC) designs, helping to differentiate products with a lower footprint.

Sidense

Series B in 2010
Sidense is a leading developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in patented one-time programmable OTP memory and logic NVM solutions that are designed for code storage and processor configuration. Sidense's technology enables semiconductor and systems companies to integrate IP cores into their system-on-chip (SOC) designs, helping to differentiate products with a lower footprint.

Sidense

Series A in 2008
Sidense is a leading developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in patented one-time programmable OTP memory and logic NVM solutions that are designed for code storage and processor configuration. Sidense's technology enables semiconductor and systems companies to integrate IP cores into their system-on-chip (SOC) designs, helping to differentiate products with a lower footprint.

APProtect

Series A in 2006
APProtect Ltd. provides anti-piracy protection solutions for consumer and business software developers and publishers. It offers Trusted Server Protection products to protect CAD tools and scientific applications in companies, universities, and other organizations; Online Software Protector family of products for protecting consumer software; and splitting machine software, which operates on a binary and splits it into two parts. The company also provides splitting, site installation, and server hosting services. APProtect Ltd. was founded in 2004 and is based in Haifa, Israel.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.